- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0039294

Novotra Pharmaceuticals Private Limited
About Novotra Pharmaceuticals Private Limited
Data last updated:
Novotra Pharmaceuticals Private Limited is a private limited company based in Baner, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 28 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2021PTC207257.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rajeev Ranjan and Rakesh Kumar Baranwal.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Richa Rohra Reelicon Alpine Ridge B/104 Sr No 13, Baner, Maharashtra, India – 411045.
As per the financials filed for FY 2023, the company reported a revenue of ₹28.77 Lakh. For the same year it recorded a net loss of ₹7.75 Lakh (net margin -26.9%) and EBITDA of -₹7.66 Lakh (EBITDA margin -26.6%).
Novotra Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0039294).
Company details
Recognitions & Rankings of Novotra Pharmaceuticals
Contact details
Novotra Pharmaceuticals Private Limited's registered office is in Baner, Maharashtra.
- Registered AddressC/O Richa Rohra Reelicon Alpine Ridge B/104 Sr No 13, Baner, Maharashtra, India – 411045
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novotra Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Novotra Pharmaceuticals Private Limited, buy the company report.
Financials of Novotra Pharmaceuticals Private Limited
FY 2023 filings availableNovotra Pharmaceuticals Private Limited reported revenue of ₹28.77 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹7.66 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹7.75 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -26.6% | |
| Net Profit Margin | -26.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Novotra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novotra Pharmaceuticals Private Limited
Novotra Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Ranjan | Director | 26 Feb 2024 | 2 Years 8 Months | Current |
| Rakesh Kumar Baranwal | Director | 22 Mar 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Novotra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novotra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Novotra Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novotra Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Abhishek Akela ceased to be Director on 01 Mar 2024.
Frequently asked questions
Novotra Pharmaceuticals is an active private limited company based in Baner, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 28 December 2021 (5+ years old) and is registered under CIN U24230PN2021PTC207257.
Novotra Pharmaceuticals has 2 current directors:
- Rajeev Ranjan - Director
- Rakesh Kumar Baranwal - Director
The latest financial statements of Novotra Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Novotra Pharmaceuticals is U24230PN2021PTC207257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novotra Pharmaceuticals was incorporated on 28 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Abhishek Akela ceased to be Director on 01 Mar 2024. Ranjeet Kumar ceased to be Director on 01 Mar 2024. Rajeev Ranjan was appointed as Director on 26 Feb 2024. Novotra Pharmaceuticals has 4 board changes on record in total.
Yes, Novotra Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0039294).
The registered office of Novotra Pharmaceuticals is at CO Richa Rohra Reelicon Alpine Ridge B104 Sr No 13, Baner, Maharashtra, India – 411045.
Novotra Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Novotra Pharmaceuticals can be reached at its registered office: CO Richa Rohra Reelicon Alpine Ridge B104 Sr No 13, Baner, Maharashtra, India – 411045.

